Hemangioendotelioma cardiaco primario recurrente: reporte de caso y revisión de la literatura

Recurrent Primary Cardiac Hemangioendothelioma: Case Report and Literature Review

Contenido principal del artículo

María Elena Pantoja Rosero
Wilfredo Antonio Rivera-Martínez
Rigoberto Gómez-Gutiérrez
María Consuelo Santamaría
Miguel Ángel Mina Hinestroza
José Dario Portillo Miño
Resumen

El hemangioendotelioma epitelioide (HEE) es un tumor maligno posiblemente de origen vascular. Su localización usual es los tejidos blandos, mediastino, sistema nervioso central, pleura, pulmones, hígado y hueso. Sin embargo, es extremadamente rara su aparición en el corazón. Se presenta el caso de un paciente masculino de 67 años de edad, quien consulta por disnea progresiva, edema de miembros inferiores y hepatomegalia congestiva dolorosa. Se diagnóstica mediante biopsia HEE cardiaco primario. Posteriormente, se documenta recidiva tumoral, razón por la que fue evaluado por la junta médica de tumores que decidió iniciar quimioterapia (paclitaxel más doxorrubicina liposomal durante 6 ciclos). El paciente continúa en seguimiento por oncología con evidencia de enfermedad estable. El HEE cardiaco es un tumor muy raro. El tratamiento con paclitaxel más doxorrubicina es un esquema de quimioterapia que puede ser considerado en el manejo del HEE cardíaco primario avanzado o recurrente después de la cirugía cardíaca.

Palabras clave

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Biografía del autor/a (VER)

María Elena Pantoja Rosero, Universidad Libre, Cali, Colombia

Médica, Residente tercer año de Medicina Interna, Facultad de Medicina, Universidad Libre, Cali. Colombia.

Wilfredo Antonio Rivera-Martínez, Universidad Libre, Cali, Colombia.

Médico, Especialista en Medicina Interna. Departamento de Medicina Interna, Universidad Libre. Cali. Colombia.

Rigoberto Gómez-Gutiérrez, Clínica Imbanaco, Cali, Colombia.

Médico, Especialista en Hematología Clínica. Departamento de Hematología, Clínica Imbanaco, Cali, Colombia.

María Consuelo Santamaría, Clínica Imbanaco, Cali, Colombia

Médica, Especialista en Patología. Departamento de Patología, Clínica Imbanaco, Cali, Colombia.

Miguel Ángel Mina Hinestroza, Universidad ICESI, Cali, Colombia.

Médico, Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia.

José Dario Portillo Miño, Fundación Universitaria San Martín

Médico, Fundación Universitaria San Martín, Pasto. Colombia.

Referencias

Requena L, Kutzner H. Hemangioendothelioma. Semin Diagn Pathol [Internet]. 2013;30, 29-44. Disponible en: https:// doi.org/10.1053/j.semdp.2012.01.003

Rosenbaum E, Jadeja B, Xu B, Zhang L, Agaram NP, Travis W, Singer S, Tap WD, Antonescu CR. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets. Mod Pathol [Internet]. 2020;33(4):591-602. Disponible en: https:// doi.org/10.1038/s41379-019-0368-8

Wu X, Li B, Zheng C, Hong T, He X. Clinical characteristics of epithelioid hemangioendothelioma: a single-center retrospective study. Eur J Med Res [Internet]. 2019;28;24(1):16. Disponible en: https://doi.org/10.1186/s40001-019-0375-8

Stacchiotti S, Frezza AM, Blay JY, et al. Ultra-rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer [Internet]. 2021;127(6):2934-2942. Disponible en: https://doi.org/10.1002/cncr.33618.

De Pinieux G, Karanian M, Le Loarer F, et al. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network. PLoS One [Internet]. 2021;16:e0246958. Disponible en: https://doi.org/10.1371/journal.pone.0246958

Petrella F, Iacono GL, Monaco F, et al. Mediastinal aortopulmonary paraganglioma. Am Surg [Internet]. 2017;83:153-4. Disponible en: https://doi.org/10.1177/00031348170830050

Messias P, Bernardo J, Antunes MJ. Primary left atrial haemangioendothelioma. Thorac Surg [Internet]. 2008;7:9454-6. Disponible en: https://doi.org/10.1510/icvts.2008.184085

Leja MJ, Shah DJ, Reardon MJ. Primary cardiac tumors. Tex Heart Inst J [Internet]. 2011;38(3):261-262. PMCID: PMC3113129. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21720466/

Huang W, Li L, Gao J, Gao JB. Epithelioid hemangioendothelioma of the right atrium invaded the superior vena cava: case report and review of literature. Int J Cardiovasc Imaging [Internet]. 2021;37(1):285-290. Disponible en: https://doi.org/doi:10.1007/s10554-020-01963-w

Petrella F, Bonalumi G, Andreini G, Camilli ED, Spaggiari L, and Alamanni F,. Primary Epithelioid Hemangioendothelioma of the Heart. Am Surg. 2018;84(6):199-200

Moidy MJ, Ibrahim OAM, Ali Khalifa EAI, Helmy SM. Right Atrial Pseudoaneurysm Complicating Epithelioid Hemangioendothelioma. Heart Views [Internet]. 2020;21(2):104-108. Disponible en: https://doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_96_19

Zhou X, Li P, Gu X, Zheng F, Zhao J, Zhao L. A case report of right atrial epithelioid hemangioendothelioma with multiple pulmonary metastases. Clin Respir J [Internet]. 2020;14(2):173-178. Disponible en: https://doi.org/10.1111/crj.13121

Ko JS, Billings SD. Diagnostically Challenging Epithelioid Vascular Tumors. Surg Pathol Clin [Internet]. 2015;8(3):331-51. Disponible en: https://doi.org/10.1016/j.path.2015.05.001

Antonescu, C. Malignant vascular tumors—an update. Mod Pathol [Internet]. 2014;27 (Suppl 1), 30-38. Disponible en: https://doi.org/10.1038/modpathol.2013.176

Deyrup AT, Tighiouart M, Montag AG, Weiss SW. Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol [Internet]. 2008;32(6):924-7. Disponible en: https://doi.org/10.1097/pas.0b013e31815bf8e6

Antonescu et al. Novel YAP1-TFE3 Fusion Defines a Distinct Subset of Epithelioid Hemangioendothelioma. Genes Chromosomes Cancer [Internet]. 2013;52(8):775-784. Disponible en: https://doi.org/10.1002/gcc.22073

Suurmeijer AJH, Dickson BC, Swanson D, Sung YS, Zhang L, Antonescu CR, Suurmeijer et al. Variant WWTR1 gene fusions in epithelioid hemangioendothelioma—A genetic subset associated with cardiac involvement. Genes Chromosomes Cancer [Internet]. 2020;59:389-395. Disponible en: https://doi.org/10. 1002/gcc.22839

Stacchiotti S, Miah AB, Frezza AM, et al. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO Open [Internet]. 2021;6(3):100170. Disponible en: https://doi.org/10.1016/j.esmoop.2021.100170

Errani C, Zhang L, Sung YS, et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer [Internet]. 2011;50:644-653. Disponible en: https://doi.org/10.1002/gcc.20886

Safirstein J, Aksenov S, Smith F. Cardiac Epithelioid Hemangioendothelioma with 8-Year Follow up. Cardiovasc Pathol [Internet]. 2007;16(3)183-6. Disponible en: https://doi.org/10.1016/j.carpath.2006.10.003

Basso C, Rizzo S, Valente M, Thiene G. Prevalence and pathology of primary cardiac tumors. Cardiovasc Med. 2012;15(1):18-29.

Stiller B, Hetzer R, Meyer R, Dittrich S, Pees C,, Meskishvili VA. Primary cardiac tumours: when is surgery necessary? Eur J Cardiothorac Surg [Internet]. 2001;20:1002-6. Disponible en: https://doi.org/10.1016/s1010-7940(01)00951-4

Y. Epelboym, et al. Imaging findings in epithelioid hemangioendothelioma. Clin Imaging [Internet]. 2019;58:59-65. Disponible en: https://doi.org/10.1016/j.clinimag.2019.06.002

Flucke U, Vogels RJ, de Saint Aubain Somerhausen N, et al. Epithelioid hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases. Diagn Pathol [Internet]. 2014;9:131. Disponible en: https://doi.org/10.1186/1746-1596-9-131

S. Arafa, and M. Sanad. Primary cardiac hemangioendothelioma of the mitral valve. Egypt Heart J [Internet]. 2018;70:229-232. Disponible en: https://doi.org/10.1016/j.ehj.2018.06.002

Sugimoto T, Yamamoto K, and Yoshii S. A Primary Epithelioid Hemangioendothelioma of the Right Atrium: Report of a Case and Literature Review. Open J Thorac Surg [Internet]. 2013;3:63-7. Disponible en: https://doi.org/10.4236/ojts.2013.32013

Stacchiotti S, Simeone N, Lo Vullo S, et al. Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: a case series analysis within the Italian rare cancer network. Cancer [Internet]. 2021;127:569-576. Disponible en: https://doi.org/10.1002/cncr.33247

Lau K, Massad M, Pollak C, et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest. 2011;140:1312-1318.

Frezza AM, Napolitano A, Miceli R, et al. Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective series within the Italian Rare Cancers Network. ESMO Open [Internet]. 2021;6:100083. Disponible en: https://doi.org/10.1016/j.esmoop.2021.100083

Gaytán-Cortés FC et al. Hemangioendotelioma cardiaco primario: diagnóstico y resección quirúrgica temprana. Rev Med Inst Mex Seguro Soc [Internet]. 2016;54(3):392-6. Disponible en: https://www.medigraphic.com/pdfs/imss/im-2016/im163s.pdf

Angelini A, Mavrogenis AF, Gambarotti M, et al. Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone. J Surg Oncol [Internet]. 2014;109(8):791-7. Disponible en: https://doi.org/10.1002/jso.23587

Ishibashi H, Takasaki C, Akashi T, Okubo K. Successful excision of epithelioid hemangioendothelioma of the superior vena cava. Ann Thorac Surg [Internet]. 2019; Disponible en: https:// doi.org/10.1016/j.athoracsur.2019.07.027.

Allain et al. Surgical Management of an Epithelioid Hemangioendothelioma of the Superior Vena Cava Protruding into the Right Atrium. J Card Surg [Internet]. 2014;29:779-781. Disponible en: https://doi.org/10.1111/jocs.12370

Lee SS, Lee JH. Surgical treatment of asymptomatic epithelioid hemangioendothelioma originating from the superior vena cava: a case report. Medicine (Baltimore) [Internet]. 2020;99:16(e19859). Disponible en: http://dx.doi.org/10.1097/MD.0000000000019859

Abu Saleh WK, Ramlawi B, Shapira OM, Al Jabbari O, Ravi V, Benjamin R, et al. Improved outcomes with the evolution of a neoadjuvant chemotherapy approach to right heart sarcoma. Ann Thorac Surg [Internet]. 2017;104:90-6. Disponible en: https://doi.org/10.1016/j.athoracsur.2016.10.054

Yin K, Zhang Z, Luo R, Ji Y, Zheng D, Lin Y et al. Clinical features and surgical outcomes of pulmonary artery sarcoma. J Thorac Cardiovasc Surg [Internet]. 2018;155:1109-15. Disponible en: https://doi.org/10.1016/j.jtcvs.2017.10.101

Mentzel T, Beham A, Calonje E, Katenkamp D, Fletcher CD. Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol [Internet]. 1997;21(4):363-74. Disponible en: https://doi.org/ 10.1097/00000478-199704000-00001

Lazarus A, Fuhrer G, Malekiani C, et al. Primary pleural epithelioid hemangioendothelioma (EHE)—two cases and review of the literature. Clin Respir J [Internet]. 2011;5(1):e1-5. Disponible en: https://doi.org/10.1111/j.1752-699X.2010.00221.x

Kim EA, Lele SM, Lackner RP. Primary pleural epithelioid hemangioendothelioma. Ann Thorac Surg [Internet]. 2011;91(1):301-2. Disponible en: https://doi.org/10.1016/j.athoracsur.2010.05.070

Zhang XQ, Chen H, Song S, Qin Y, Cai LM, Zhang F. Effective combined therapy for pulmonary epithelioid hemangioendothelioma: A case report. World J Clin Cases [Internet]. 2020;26;8(10):2009-2015. Disponible en: https://doi.org/10.12998/wjcc.v8.i10.2009

Din NU, Rahim S, Asghari T, Abdul-Ghafar J, Ahmad Z. Hepatic epithelioid hemangioendothelioma: case series of a rare vascular tumor mimicking metastases. Diagn Pathol [Internet]. 2020;25;15(1):120. Disponible en: https://doi.org/10.1186/s13000-020-01039-2

Ye B, Li W, Feng J, Shi J-X, Chen Y, Han B-H. Treatment of pulmonary epithelioid hemangioendothelioma with combination chemotherapy: Report of three cases and review of the literature. Oncol Lett [Internet]. 2013;5:1491-1496. Disponible en: https://doi.org/10.3892/ol.2013.1217

Zou, Z., Tao, T., Li, H. et al. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci [Internet]. 2020;10(31):1-11. Disponible en: https://doi.org/10.1186/s13578-020-00396-1

Wan X, Helman LJ. The biology behind mTOR inhibition in sarcoma. Oncologist [Internet]. 2007;12(8):1007-1018. Disponible en: https://doi.org/10.1634/theoncologist.12-8-1007

Witte S, Weidema M, Kaal S, et al. The heterogeneity of Epithelioid Hemangioendothelioma (EHE): A case series and review of the literature with emphasis on treatment options. Semin Oncol [Internet]. 2021;48(2):111-118. Disponible en: https://doi.org/10.1053/j.seminoncol.2021.04.002

Semenisty V, Naroditsky I, Keidar Z, et al. Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options. BMC Cancer [Internet]. 2015;15:402. Disponible en: https://doi.org/10.1186/s12885-015-1395-6

Kobayashi N, Shimamura T, Tokuhisa M, et al. Sorafenib monotherapy in a patient with unresectable hepatic epithelioid hemangioendothelioma. Case Rep Oncol [Internet]. 2016;9(1):134-7. Disponible en: https://doi.org/10.1159/000443986

Agulnik M, Yarber JL, Okuno SH, et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol [Internet]. 2013;24(1):257-63. Disponible en: https://doi.org/10.1093/annonc/mds237

Sangro B, Iñarrairaegui M, Fernández-Ros N. Malignant epithelioid hemangioendothelioma of the liver successfully treated with sorafenib. Rare Tumors [Internet]. 2012;4:106-109. Disponible en: https://doi.org/10.4081/rt.2012.e34

Stacher E, Gruber-Mösenbacher U, Halbwedl I, et al. The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets? Lung Cancer [Internet]. 2009;65:49-55. Disponible en: https://doi.org/10.1016/j.lungcan.2008.10.031

Chevreau C, Le Cesne A, Ray-Coquard I, Italiano A, Cioffi A, Isambert N et al. Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO). Cancer [Internet]. 2013;119: 2639-2644. Disponible en: https://doi.org/10.1002/cncr.28109

Kyriazoglou A, Koutsoukos K, Zagouri F, et al. Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?. Ther Clin Risk Manag [Internet]. 2020;16:141-146. Disponible en: https://doi.org/10.2147/TCRM.S220804

Fukuhara S, Tahara H, Hirata Y, Ono K, Hamaoka M, Shimizu S, Hashimoto S, Kuroda S, Ohira M, Ide K, Kobayashi T, Ohdan H. Hepatic epithelioid hemangioendothelioma successfully treated with living donor liver transplantation: A case report and literature review. Clin Case Rep [Internet]. 2019;17;8(1):108-115. Disponible en: https://doi.org/10.1002/ccr3.2558

Aksoy EA, Atalar B, Beylergil V, et al. Unresectable epithelioid hemangioendothelioma of the neck region cured by radiotherapy. J Med Cases [Internet]. 2011;2:147-150. Disponible en: https://doi.org/10.4021/jmc216w

Cottini M, Lappa A, Donfrancesco S. Primary cardiac hemangioendothelioma in the adult and cardiac involvement in patient with non-cardiac hemangioendothelioma. Review of literature. Cancer Stud Ther J [Internet]. 2017;2:1-6. Disponible en: https://doi.org/10.31038/CST.2017253

Sistema OJS - Metabiblioteca |